BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

ビジネス · 1994/8/22 分で読めます

Findings of Scientific Misconduct

ローカル自動翻訳 · 情報源の原言語

概要

Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Annmarie Surprenant, Ph.D., Glaxo Institute for Molecular Biology. An inquiry and investigation conducted by the Oregon Health Sciences University (OHSU) found that Annmarie Surprenant, Ph.D., had misrepresented her academic credentials in a grant application for Public Health Service (PHS) research funds. The OHSU found that Dr. Surprenant had falsely stated that she had earned an M.K. degree from the University of Illinois at Chicago in 1976. As a result of the OHSU investigation, Dr. Surprenant resigned from the OHSU faculty. During its oversight review of the OHSU report, the Office of Research Integrity (ORI) discovered that Dr. Surprenant had also falsely claimed to have earned an M.D. on two additional PHS research grant applications. Based upon the OHSU report, as well as the information obtained by ORI during its oversight review, ORI found that Dr. Surprenant engaged in scientific misconduct by falsely claiming to have earned an M.D. in three PHS research grant applications. Dr. Surprenant accepted the ORI finding and agreed to a Volun

情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →

関連インサイト

ビジネスインサイト →